Find clinical trials for Chronic Lymphocytic Leukemia in Pittsburgh, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Chronic Lymphocytic Leukemia trials near Pittsburgh, PA, USA:
This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 79 other locations
ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refractory chronic...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 38 other locations
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) composed of autologous PBL (Peripheral Blood Lymphocytes) in patients...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 2 other locations
The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination wit...
Phase 3
Pittsburgh, Pennsylvania, United States and 170 other locations
this approach to reliably generate product and to safely administer the product to patients who have B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia...
Phase 2
Pittsburgh, Pennsylvania, United States
\[DLBCL\], adult T-cell leukemia-lymphoma \[ATL\], and indolent non Hodgkin lymphomas such as follicular lymphoma \[FL\] and chronic...
Phase 1
Pittsburgh, Pennsylvania, United States and 9 other locations
The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritamab, an ant...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 84 other locations
GSK-3β is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and e...
Phase 2
Pittsburgh, Pennsylvania, United States and 65 other locations
evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 33 other locations
Clinical trials
Research sites
Resources
Legal